Compare BBNX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBNX | AHCO |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2025 | N/A |
| Metric | BBNX | AHCO |
|---|---|---|
| Price | $29.39 | $9.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $28.09 | $13.60 |
| AVG Volume (30 Days) | 618.5K | ★ 910.8K |
| Earning Date | 10-28-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.55 |
| Revenue | $88,570,000.00 | ★ $3,255,213,000.00 |
| Revenue This Year | $52.13 | $0.89 |
| Revenue Next Year | $36.16 | $6.84 |
| P/E Ratio | ★ N/A | $17.20 |
| Revenue Growth | ★ 67.01 | N/A |
| 52 Week Low | $8.89 | $7.11 |
| 52 Week High | $32.71 | $11.63 |
| Indicator | BBNX | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 55.31 | 49.25 |
| Support Level | $27.87 | $9.26 |
| Resistance Level | $31.51 | $9.84 |
| Average True Range (ATR) | 2.09 | 0.38 |
| MACD | -0.22 | -0.02 |
| Stochastic Oscillator | 47.23 | 33.61 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.